Related Experiment Video
Updated: May 6, 2026
A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
In Silico Hybridization and Molecular Dynamics Simulations for the Identification of Candidate Human MicroRNAs for
Harshita Tiwari1, Subhadip Saha1, Monidipa Ghosh1
1Department of Biotechnology, National Institute of Technology, Durgapur, India.
Abstract:
Staphylococcus aureus is a major threat to human health, causing infections that range in severity from moderate to fatal. The rising rates of antibiotic resistance highlight the critical need for new therapeutic techniques to combat this infection. It has been recently discovered that microRNAs (miRNAs) are essential for cross-kingdom communication, especially when it comes to host-pathogen interactions. It has been demonstrated that these short noncoding RNAs control gene expression in the gut microbiota, maintaining homeostasis; dysbiosis in this system has been linked to several diseases, including cancer. Our research attempts to use this understanding to target specific bacterial species and prevent severe diseases. In particular, we look for putative human miRNAs that can attach to virulent bacterial proteins' mRNA and prevent them from being expressed. In-silico hybridization experiments were performed between 100 human miRNA sequences with varied expression levels in gram-positive bacterial infections and five virulence factor genes. In addition, these miRNAs' binding properties were investigated using molecular dynamics (MD) simulations. Our findings demonstrate that human miRNAs can target and inhibit the expression of bacterial virulent genes, thereby opening up new paths for developing innovative miRNA-based therapeutics. The implementation of MD simulations in our study not only improves the validity of our findings but also proposes a new method for constructing miRNA-based therapies against life-threatening bacterial infections.
Insights
Human microRNAs (miRNAs) can inhibit Staphylococcus aureus virulence factors. This discovery offers a novel approach for developing new miRNA-based therapies against dangerous bacterial infections.
Area of Science:
- Microbiology
- Genetics
- Bioinformatics
Background:
- Staphylococcus aureus infections pose a significant health risk, exacerbated by increasing antibiotic resistance.
- MicroRNAs (miRNAs) play a crucial role in host-pathogen interactions and maintaining gut microbiota homeostasis.
- Dysbiosis in the gut microbiota is linked to various diseases, including cancer.
Purpose of the Study:
- To identify human miRNAs capable of targeting and inhibiting the expression of mRNA from virulent bacterial proteins.
- To explore novel therapeutic strategies against Staphylococcus aureus infections using miRNA-based approaches.
Main Methods:
- In-silico hybridization experiments were conducted between human miRNA sequences and mRNA of five key Staphylococcus aureus virulence factor genes.
- Molecular dynamics (MD) simulations were employed to investigate the binding properties and stability of miRNA-mRNA interactions.
Main Results:
- The study identified specific human miRNAs that can effectively bind to and inhibit the expression of bacterial virulence factor genes.
- MD simulations validated the binding interactions, confirming the potential of these miRNAs as therapeutic agents.
Conclusions:
- Human miRNAs demonstrate the potential to target and suppress essential bacterial virulence genes.
- This research presents a novel strategy for developing innovative miRNA-based therapeutics against severe bacterial infections, supported by MD simulations.
